Cargando…
Characterization of a new mouse p53 variant: loss-of-function and gain-of-function
BACKGROUND: p53 is a major tumor suppressor that is inactivated in over 50% of human cancer types through either mutation or inactivating interactions with viral or cellular proteins. The uncertainties around the link between p53 status, therapeutic response, and outcome in cancer suggest that addit...
Autores principales: | Chan, James Yi-Hsin, Chen, Ying-Chuan, Liu, Shu-Ting, Chou, Wei-Yuan, Ho, Ching-Liang, Huang, Shih-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022406/ https://www.ncbi.nlm.nih.gov/pubmed/24884657 http://dx.doi.org/10.1186/1423-0127-21-40 |
Ejemplares similares
-
p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
por: Alexandrova, Evguenia M, et al.
Publicado: (2017) -
Risk alleles of genes with monoallelic expression are enriched in gain-of-function variants and depleted in loss-of-function variants for neurodevelopmental disorders
por: Savova, Virginia, et al.
Publicado: (2017) -
Regulators of Oncogenic Mutant TP53 Gain of Function
por: Yamamoto, Satomi, et al.
Publicado: (2018) -
Gain-of-function mutant p53: history and speculation
por: Bargonetti, Jill, et al.
Publicado: (2019) -
Distinct Calcium Signaling for Wildtype, Loss-of-Function and Gain-of-Function Human MC4R Variants
por: Kumar, Shree S, et al.
Publicado: (2021)